Impact of COVID-19 on pediatric oncology
Abstract
The worldwide coronavirus disease 19 (COVID-19) pandemic led to a critical situation in the healthcare system concerning patients suffering from cancer and chronic diseases. It had the effect of causing them anxiety and reluctance to seek immediate medical attention when required due to the fear of COVID-19’s potentially acute and life-threatening states.
The main issues concerning pediatric patients in this regard are the reluctance to seek pediatric care leading to delayed referrals for severe conditions, including children’s neoplasms, that show a history of symptoms indicating cancer that has been present for weeks. The risk of prolonging diagnoses of pediatric neoplasms may be incomparably more threatening than the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection itself. The incidence of SARS-CoV-2 positivity in children with neoplasms is low, and the majority of them have a mild or moderate course of infection. A physical examination of a child with a history of symptoms indicating cancer is crucial to proper evaluation.
It is essential to minimise the risk of detecting advanced childhood cancer to prevent children from experiencing neoplasms that are otherwise highly curable if diagnosed early, in addition to possible long-term complications and increased mortality.
Keywords: oncologychildrenCOVID-19
References
- Styczyński J, Balwierz W, Wachowiak J, et al. Epidemiology and prevention strategies of SARS-CoV-2 infection in pediatric hematology and oncology centers in Poland. Acta Haematologica Polonica. 2020; 51(4): 253–257.
- Ciacchini B, Tonioli F, Marciano C, et al. Reluctance to seek pediatric care during the COVID-19 pandemic and the risks of delayed diagnosis. Ital J Pediatr. 2020; 46(1): 87.
- Agostiniani R, Bozzola E, Staiano A, et al. Providing pediatric well-care and sick visits in the COVID-19 pandemic era: the recommendations of the Italian pediatric society. Ital J Pediatr. 2020; 46(1): 133.
- Carai A, Locatelli F, Mastronuzzi A. Delayed referral of pediatric brain tumors during COVID-19 pandemic. Neuro Oncol. 2020; 22(12): 1884–1886.
- Bouffet E, Challinor J, Sullivan M, et al. Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences. Pediatr Blood Cancer. 2020; 67(7): e28327.
- Wolfs TFW, Attarbaschi A, Balduzzi A, et al. COVID-19 - impact on childhood haematology patients. Hemasphere. 2020; 4(5): e465.
- Dorantes-Acosta E, Ávila-Montiel D, Klünder-Klünder M, et al. Survival and complications in pediatric patients with cancer and COVID-19: a meta-analysis. Front Oncol. 2020; 10: 608282.
- Vasquez L, Sampor C, Villanueva G, et al. Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America. Lancet Oncol. 2020; 21(6): 753–755.
- Sullivan M, Bouffet E, Rodriguez-Galindo C, et al. The COVID-19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer. 2020; 67(7): e28409.
- Shoag JM, Barredo JC. The impact of COVID-19 pandemic on pediatric oncology. CellR4. 2020; 8: e2854.
- Lazzerini M, Barbi E, Apicella A, et al. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020; 4(5): e10–e11.
- Ding YY, Ramakrishna S, Long AH, et al. Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic. Pediatr Blood Cancer. 2020; 67(9): e28427.
- Offenbacher R, Knoll MA, Loeb DM. Delayed presentations of pediatric solid tumors at a tertiary care hospital in the Bronx due to COVID-19. Pediatr Blood Cancer. 2021; 68(2): e28615.
- Chiaravalli S, Ferrari A, Sironi G, et al. A collateral effect of the COVID-19 pandemic: delayed diagnosis in pediatric solid tumors. Pediatr Blood Cancer. 2020; 67(10): e28640.